Evidence map›Paper›PMID 39532265›Full record

ArticleNeurobiology of disease2024

Deciphering the alteration of MAP2 interactome caused by a schizophrenia-associated phosphorylation.

Jiali Lyu, Matthew L MacDonald, Shelby Ruiz, Shinnyi Chou, Jordan Gilardi, Serena C Buchwald, Melanie J Grubisha, Robert A Sweet

Abstract read
In one paragraph

Article in Neurobiology of disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Association ofFrontiers in psychiatry · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiali LyuSchool of Medicine, Tsinghua University, China; Translational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, United States of America.
Matthew L MacDonaldTranslational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, United States of America; Health Sciences Mass Spectrometry Core, University of Pittsburgh, United States of America.
Shelby RuizDepartment of Neurobiology, University of Pittsburgh, United States of America.
Shinnyi ChouTranslational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, United States of America.
Jordan GilardiTranslational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, United States of America.
Serena C BuchwaldTranslational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, United States of America.
Melanie J GrubishaTranslational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, United States of America.
Robert A SweetTranslational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, United States of America; Department of Neurology, University of Pittsburgh, United States of America. Electronic address: sweetra@upmc.edu.

Funding

Predoctorial Training in Basic NeuroscienceT32NS007433 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MERINEY, STEPHEN D · 1998 to 2022
$8.0M
Synaptic Resilience to Psychosis in Alzheimer DiseaseR01MH116046 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Julia K Kofler, ROBERT A SWEET · 2018 to 2026
$6.6M
Fine-Mapping Genome-Wide Associated Loci using Multi-omics Data to Identify Mechanisms Affecting Serious Mental IllnessR01MH125235 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEVLIN, BERNIE, MACDONALD, MATTHEW L · 2021 to 2024
$3.0M
Synaptic Protein Networks, Genetic Risk, and Spine Loss in SchizophreniaR01MH118497 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MACDONALD, MATTHEW L · 2019 to 2023
$2.5M
Providing New Insight Into Adolescent Dendritic DevelopmentR01MH132586 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Melanie Jean Grubisha · 2024 to 2026
$1.7M
Enhanced NGR/p75/KAL9 Signaling and Impaired Dendritic Morphogenesis in Schizophrenia - SupplementK08MH118513 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GRUBISHA, MELANIE JEAN · 2019 to 2023
$805k
NIMH NIH HHS K08 MH118513NIMH NIH HHS R01 MH116046NIMH NIH HHS R01 MH118497NIMH NIH HHS R01 MH125235NIMH NIH HHS R01 MH132586
6 · The paper itself

Abstract

Microtubule-associated protein 2 (MAP2) is a crucial regulator of dendritic structure and neuronal function, orchestrating diverse protein interactions within the microtubule network. We have shown MAP2 is hyperphosphorylated at serine 1782 (S1782) in schizophrenia and phosphomimetic mutation of S1782 in mice (MAP2

Indexed as

Microtubule-Associated ProteinsSchizophreniaAnimalsDendritesHumansMiceMice, Inbred C57BLMice, TransgenicPhosphorylationMicrotubule-Associated ProteinsMtap2 protein, mouseMAP2PhosphorylationProtein-protein interactionProteomics

Identifiers

PMID39532265
PMCPMC12413633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.